Published in Obesity and Diabetes Week, January 19th, 2004
Ortec submitted the Manufacturing and Controls (CMC) section, the first of two modules of the application. The final section of the PMA, which will include a summary of safety and effectiveness in the clinical studies and device labeling, is expected to be filed with the FDA at the end of January 2004.
Ortec recently announced that in agreement with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week